Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
On September 7, 2026, the exchange noted a significant increase in Zydus Wellness Limited's trading volume and had written to the company for a response, which was still awaited. By September 8, 2026, the company had submitted its response regarding the volume spurt.
As of September 18, 2026, Zydus Wellness Limited's closing price was ₹522.25. Daily technical indicators showed a 'bullish' Supertrend at 512.56. Monthly indicators also showed a 'bullish' Supertrend at 352.21. Nearest resistance levels were observed around ₹535.48 and ₹537.59, while the nearest support level was noted at ₹477.1.
In the six months leading up to September 18, 2026, Zydus Wellness Limited returned 0.22. Year-to-date performance was 0.12, and since the start of trading, the return was 0.32. Over the last month, the stock returned 0.05, while the return over the last year was 0.0.
Zydus Wellness Limited informed the exchange about an ESG rating assigned by SES on September 3, 2026. Additionally, the company shared the transcript of its 32nd Annual General Meeting on September 2, 2026, and reported a change in Directors/KMP/SMP/Auditor/RTA on September 1, 2026.
As of 18 Sept 2026, 03:30 pm
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price swings are higher than typical
The session traded across a materially wider price range than usual.
Larger price swings can increase short-term uncertainty, especially if they continue.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | ₹1,437 crore | PEAK₹1,484.70 crore | ₹964.90 crore | ₹650.50 crore | ₹860.90 crore |
| Finance Costs | ₹26.30 crore | ₹38.70 crore | PEAK₹41.20 crore | ₹15.70 crore | ₹2.50 crore |
| Profit Before Exceptional Items And Tax | ₹162.10 crore | PEAK₹177.30 crore | -₹34.90 crore | -₹16.40 crore | ₹145.30 crore |
| Profit Before Tax | ₹162.10 crore | PEAK₹177.30 crore | -₹41.50 crore | -₹50.60 crore | ₹145.30 crore |
| Tax Expense | PEAK₹43.20 crore | ₹15.30 crore | -₹1.60 crore | ₹2.20 crore | ₹17.40 crore |
| Profit Loss For Period | ₹118.90 crore | PEAK₹162 crore | -₹39.90 crore | -₹52.80 crore | ₹127.90 crore |
The quarter demonstrated that a large increase in revenue did not lead to higher net profit. Zydus Wellness achieved a 66.92% increase in revenue year-over-year, yet net profit fell by 7.04%. Sharply higher finance costs and a more than doubling of the tax expense absorbed the gains from the larger revenue base, resulting in thinner margins and a lower bottom line.
Exchange disclosures and regulatory announcements for Zydus Wellness.
Zydus Wellness Limited has informed the Exchange about change in Management |SUBJECT: Change in Management
ZYDUS WELLNESS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Zydus Wellness Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response. |SUBJECT: Spurt in Volume
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |SUBJECT: Spurt in Volume
Zydus Wellness Limited has informed the Exchange about ESG rating assigned by SES |SUBJECT: General Updates
Zydus Wellness Limited has informed the Exchange about Transcript of 32nd Annual General Meeting |SUBJECT: General Updates
Recent market and company developments associated with Zydus Wellness.
Some Nifty 500 stocks rallied at market open, while others slid on an executive exit report and profit booking — here's a look at today's top gainers and losers.
Volume shocker stocks today: Stocks such as Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness surged in morning deals on Monday, 7 September, amid a spurt in volume.
India Business News: Mumbai: Protein foods are now a common sight across retail shelves, but consumers may increasingly also have the choice to go for smaller-sized portio.
Market expert Raja Venkatraman shares his top stock picks for 26 August. Here’s his technical outlook and trade strategy.
Q1 Results Today, 4th August 2026 Live Updates: Follow businessline for more
Zydus Wellness posted a consolidated net profit of ₹119 crore for the June quarter, compared with ₹128 crore in the corresponding period last year. Revenue from operations surged 67% year-on-year to ₹1,437 crore from ₹860.9 crore.
Stock Market LIVE Updates: Today's session is not only the weekly options expiry session for the Nifty 50 contracts, but is also set to see supply of paper worth nearly ₹36,000 crore, which includes the mega LIC Offer for Sale (OFS). Earnings season is drawing to a close and therefore, companies are making a beeline to report numbers as well. Adding to that is the confusion surrounding the Closing Auction Session. Watch this space for all the LIVE stock market updates.
Q1 Results LIVE Updates: Two Nifty 50 companies Bharti Airtel, ONGC and Ajmera Realty, Alembic Pharma, BSE, Bharti Hexacom, Castrol, Godrej Properties, Greaves Cotton, Kalyan Jewellers, Marico, MCX, Nykaa, Metro Brands, NHPC, Motherson Sumi Wiring, Pidilite, Protean e-GOV, Keystone Realtors, RITES, Saregama, Safari Industries, Sanofi India, Tata Investment, Symphony, United Breweries, Uno Minda, VRL Logistics, Zydus Wellness, Welspun Enterprises, Wonderla Holidays, Prince Pipes, Metropolis Healthcare, CE InfoSystems, are among the other companies reporting their numbers today. Earnings reactions also come from stocks like DLF, IREDA, Torrent Power, and other such names.
Comprehensive Section Breakdown for Zydus Wellness
Strategic Vision: Consumer wellness company with Indian heritage and global presence.
• Diverse portfolio of brands across multiple wellness segments.
• Extensive distribution channels including ground sales, business partners, and direct market access.
• Global operational footprint with manufacturing and co-manufacturing facilities.
Opening Summary Zydus Wellness reported ₹1,437 crore in revenue for the quarter ended 30 June 2026, a 66.92% increase from the same period last year. Sequentially, revenue dipped slightly by 3.21% from the preceding quarter’s ₹1,484.70 crore. Despite the larger top line, net profit fell to ₹118.90 crore from ₹127.90 crore a year ago. Pre-tax profit rose modestly to ₹162.10 crore, but a sharp rise in finance costs and a substantial increase in the tax charge absorbed the gains, compressing margins.
Revenue reached ₹1,437 crore in the first quarter of FY2026-27. Compared to the year-ago quarter, this represents an increase of ₹576.10 crore. Sequentially, revenue decreased by ₹47.70 crore, or 3.21%, from the ₹1,484.70 crore recorded in the March quarter. Over the past five quarters, revenue moved from ₹860.90 crore in Q1 FY2025-26 to a low of ₹650.50 crore in the September quarter, before rising to ₹1,484.70 crore in December and settling near that peak in the current quarter.
While revenue nearly doubled year-over-year, pre-tax profit grew by 11.56%, rising from ₹145.30 crore to ₹162.10 crore. This disparity indicates that the overall profitability per rupee of sales declined. The pre-tax profit margin contracted from 16.88% in the year-ago quarter to 11.28% in the current quarter. Similarly, the net profit margin fell from 14.86% to 8.27%. The business generated a larger revenue base, but a smaller portion of each rupee flowed through to the bottom line compared to the previous year.
Finance costs were recorded at ₹26.30 crore for the quarter. This marks a significant increase of ₹23.80 crore compared to the ₹2.50 crore reported in the same quarter last year. In the context of a net profit of ₹118.90 crore, this additional cost represents a notable drag on earnings. However, finance costs have declined from their recent peaks of ₹41.20 crore in the September quarter and ₹38.70 crore in the December quarter, falling by 32.04% sequentially.
The most direct factor explaining the decline in net profit is the tax expense. The tax charge for the quarter was ₹43.20 crore, an increase of 148.28% from the ₹17.40 crore paid in the year-ago quarter. Pre-tax profit increased by ₹16.80 crore year-over-year, but the tax bill increased by ₹25.80 crore. Consequently, the net result was a reduction in profit after tax. The effective tax rate on pre-tax profit rose to 26.65% in the current quarter, compared to 11.97% in the prior year.
Net profit for the period stood at ₹118.90 crore. This marks a 7.04% decrease year-over-year and a 26.6% decrease from the ₹162 crore reported in the preceding quarter. The company returned to profitability after recording losses in the second and third quarters of FY2025-26.
Comprehensive income for the period was ₹107.90 crore, which is ₹11 crore below the net profit. This is the widest gap between the two measures across the five quarters shown, indicating that items recognized outside the income statement reduced total comprehensive income more significantly in this quarter than in previous periods.
Basic and diluted earnings per share from continuing operations were ₹3.74. This represents an 81.39% decline from the ₹20.10 reported a year ago. The drop in per-share earnings is far steeper than the 7.04% fall in net profit, despite the paid-up value of equity share capital remaining unchanged at ₹63.60 crore throughout the period. This divergence indicates a change in the number of shares used in the per-share calculation.
Category: Consumer Goods
This segment includes a range of food and nutrition products designed to meet consumer health and dietary needs.
Key Products & Services: RiteBite Max Protein • Complan • Sugar Free • Sugar Free D’Lite • I’m Lite • Glucon-D • Nutralite
Category: Health and Wellness
The company offers dietary supplements aimed at supporting health and wellness.
Key Products & Services: WeightWorld • MaxMedix
Category: Consumer Goods
This segment focuses on natural and safe food supplements for dogs and cats, primarily for European and US markets.
Key Products & Services: Animigo
Category: Personal Care
The company provides skincare products to address personal care needs.
Key Products & Services: Everyuth • Nycil
Core Thesis: The company's diverse brands collectively reinforce its vision of promoting wellness by addressing various consumer needs within health and personal care.
• Manufacturing Integrity: The company's operations are supported by manufacturing facilities in India and co-manufacturing facilities globally. • Supply Chain Efficiency: A broad global supply chain and distribution network extends across more than 25 countries and three continents. • Product Innovation: The company offers a diverse portfolio of innovative products across various wellness segments.